MAP Congress 2018: Interpreting molecular alterations for clinical practice

(European Society for Medical Oncology) The Molecular Analysis for Personalised therapy (MAP) Congress is a one-of-a-kind meeting designed to answer the critical question about how to integrate the wealth of information coming from the analysis of tumour samples into daily practice.

Comments
%d bloggers like this: